...
首页> 外文期刊>BMC Medical Research Methodology >Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial - lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)
【24h】

Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial - lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)

机译:癌症筛查试验中提交给终点委员会的死亡原因分配信息的标准化-从CAP汲取的经验教训(针对前列腺癌的PSA检测的集群随机试验TriAl)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background In cancer screening trials where the primary outcome is target cancer-specific mortality, the unbiased determination of underlying cause of death (UCD) is crucial. To minimise bias, the UCD should be independently verified by expert reviewers, blinded to death certificate data and trial arm. We investigated whether standardising the information submitted for UCD assignment in a population-based randomised controlled trial of prostate-specific antigen (PSA) testing for prostate cancer reduced the reviewers’ ability to correctly guess the trial arm. Methods 415,000 men aged 50–69 years) were cluster-randomised to PSA testing (intervention arm) or the National Health Service (NHS) prostate cancer risk management programme (control arm) between 2001 and 2007. Assignment of UCD was by independent reviews of researcher-written clinical vignettes that masked trial arm and death certificate information. A period of time after the process began (the initial phase), we analysed whether the reviewers could correctly identify trial arm from the vignettes, and the reasons for their choice. This feedback led to further standardisation of information (second phase), after which we re-assessed the extent of correct identification of trial arm. Results 1099 assessments of 509 vignettes were completed by January 2014. In the initial phase (n?=?510 assessments), reviewers were unsure of trial arm in 33% of intervention and 30% of control arm assessments and were influenced by symptoms at diagnosis, PSA test result and study-specific criteria. In the second phase (n?=?589), the respective proportions of uncertainty were 45% and 48%. The percentage of cases whereby reviewers were unable to determine the trial arm was greater following the standardisation of information provided in the vignettes. The chances of a correct guess and an incorrect guess were equalised in each arm, following further standardisation. Conclusions It is possible to mask trial arm from cause of death reviewers, by using their feedback to standardise the information submitted to them. Trial registration ISRCTN92187251
机译:背景技术在以主要癌症特异性死亡率为主要目标的癌症筛查试验中,无偏见地确定潜在的死亡原因(UCD)是至关重要的。为了最大程度地减少偏差,应由专家审阅者对UCD进行独立验证,对死亡证明数据和审判部门不知情。我们调查了在基于人群的前列腺癌前列腺特异性抗原(PSA)测试随机对照试验中,对提交给UCD分配的信息进行标准化是否会降低审阅者正确猜出试验臂的能力。方法在2001年至2007年之间,对415,000名年龄在50-69岁之间的男性进行了分组随机分组以进行PSA测试(干预组)或国家卫生局(NHS)前列腺癌风险管理计划(对照组)。由研究人员撰写的临床短片掩盖了试验手臂和死亡证明信息。在流程开始后的一段时间内(初始阶段),我们分析了审稿人是否可以从小插曲中正确识别试验臂,以及他们选择的原因。这种反馈导致信息的进一步标准化(第二阶段),此后,我们重新评估了正确识别试验机构的程度。结果到2014年1月,完成了1099次对509个晕影的评估。在初始阶段(n = 510评估),审阅者不确定33%的干预措施和30%的对照组的评估方法是否适用于试验组,并且在诊断时受到症状的影响,PSA测试结果和特定于研究的标准。在第二阶段(n≥589),不确定度的比例分别为45%和48%。随着小插图中提供的信息标准化,审阅者无法确定审判部门的案件所占的百分比更高。在进一步标准化之后,每组的正确猜测和错误猜测的机会均等。结论可以通过使用死者复查者的反馈来标准化提交给他们的信息,从而使死者复查者免受掩盖。试用注册ISRCTN92187251

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号